ArticleJournal of clinical and diagnostic research : JCDR2017
Study on MICs of Tigecycline in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae (CRE) at a Tertiary Care Centre in North India.
Article in Journal of clinical and diagnostic research : JCDR, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 21 citations in OpenAlex.
- Imipenem resistance inNew microbes and new infections · 2026Review
- Carbapenem-Resistant Gram-Negative Bacilli in Mauritania: A Major Public Health Threat.MicrobiologyOpen · 2026Article
- Phenotypic characterisation and prevalence of carbapenem-resistant Enterobacterales in a tertiary care centre in Bihar India.Scientific reports · 2025Article
- Bacterial isolation and genome analysis of a novel Klebsiella quasipneumoniae phage in southwest China's karst area.Virology journal · 2024Article
- Evaluation of role of Tigecycline among clinically significant multidrug resistant pathogens from a tertiary care hospital.F1000Research · 2024Article
- Use of Newer and Repurposed Antibiotics against Gram-Negative Bacteria in Neonates.Antibiotics (Basel, Switzerland) · 2023Review
- Reduced susceptibility to carbapenems inThe Pan African medical journal · 2023Article
- Emerging Carbapenem-ResistantInfection and drug resistance · 2021Review
- Risk Factors of Multidrug Resistant Pathogens Induced Infection in Severe Acute Pancreatitis.Shock (Augusta, Ga.) · 2020Article
- Contribution ofThe Indian journal of medical research · 2019Article
- Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria.The Indian journal of medical research · 2019Article
- Gut Colonization with Carbapenem-resistant Enterobacteriaceae Adversely Impacts the Outcome in Patients with Hematological Malignancies: Results of A Prospective Surveillance Study.Mediterranean journal of hematology and infectious diseases · 2018Article
- Epidemiology of carbapenem-resistant Enterobacteriaceae in a Tertiary Care Center in the Kingdom of Bahrain.Journal of laboratory physiciansArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMembers of family
aimTo evaluate the MIC values of tigecycline against carbapenem resistant MATERIALS AND
methodsThis prospective study was carried out from January 2015 to December 2015 at the Department of Microbiology, Era's Lucknow Medical College and Hospital (ELMCH), Lucknow, Uttar Pradesh, India. Antimicrobial susceptibility by disk diffusion (Kirby-bauer) was done for 491
resultsOut of 491 isolates tested, 186 (37.9%) were found to be CRE showing resistance to at least one of the three carbapenems tested and these included 99
conclusionA high prevalence of carbapenem resistance coupled with high tigecycline MICs in clinical isolates of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.